This spring, the New Jersey Health Foundation awarded Rowan University more than $1.18 million in seed funding to advance ...

Oseremen Onolememen, who had sickle cell disease, was in severe pain when admitted to the emergency department in 2023 ...

Aicuris’s pritelivir is forecast to be a significant advancement for immunocompromised patients with refractory HSV ...

Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced multiple presentations at the 2026 American ...

Most people picture dementia as something that creeps up in old age, something that belongs to a distant future most of us ...

Innovative Molecules' adibelivir had a favourable pharmacokinetic profile and proved safe and efficacious in Phase I clinical ...

By Swasti Chatterjee A video of Uttar Pradesh police assaulting women surfaced on social media in the backdrop of violent protests in Noida over salary hike last week. The disturbing visuals show ...

Malawi’s economic trajectory between 2020 and 2025 has been marked by repeated currency devaluations, sharp increases in the ...

Additional Phase 1b data for ABI-5366, including results from monthly dosing cohort, selected for oral presentation – – Phase 1b data from ABI-1179 accepted for late-breaker poster presentation – ...

Grace Miller was a 24-year-old law school student when she was diagnosed with multiple sclerosis. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive content.

Luciano Costa waited three years to see how patients with an aggressive bone-marrow cancer would fare on an experimental immunotherapy treatment. Reviewing the results gave him goose bumps. “Holy shit ...

Many people with multiple sclerosis struggle with balance and coordination, and this study uncovers a hidden reason why. Researchers found that inflammation in the brain disrupts the energy supply of ...